Rheumatology
Conference Coverage
COVID-19 vaccine won’t be a slam dunk
A key safety concern to watch for in the coming months is whether a vaccine candidate is able to sidestep the issue of antibody-dependent...
Conference Coverage
TNF inhibitors may dampen COVID-19 severity
New findings from the COVID-19 Global Rheumatology Alliance Registry.
News
ACR gives guidance on rheumatic disease management during pandemic
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
Conference Coverage
Biologics better solo than with methotrexate in psoriatic arthritis
Ustekinumab or a tumor necrosis factor inhibitor are better used alone than with methotrexate in the treatment of psoriatic arthritis.
News
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Price increases for RA biologics keep out-of-pocket costs high for Medicare patients
Yearly increases in the price of rheumatoid arthritis biologics have largely negated initial savings in out-of-pocket costs tied to the Affordable...
News
COVID-19: Frequently asked clinical questions
Should I continue to vaccinate my pediatric population during peak COVID-19?
News
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
Data for a total of 583 COVID-19 patients have now been made available.
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
Latest News
Most e-consults not followed by specialist visit
The results reflect experts’ positive experiences with e-consults.